Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Brown University
Thomas Jefferson University
Incyte Corporation
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline
Pfizer
City of Hope Medical Center
Washington University School of Medicine
University of Nebraska
University of Nebraska
University of Nebraska
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Northside Hospital, Inc.
Amgen
Fred Hutchinson Cancer Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
Northside Hospital, Inc.
Merck Sharp & Dohme LLC
Kiadis Pharma
West Virginia University
University of Chicago
Novartis
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center